MERS-CoV at the Animal-Human Interface: Inputs on Exposure Pathways from an Expert-Opinion Elicitation

Anna L Funk1, Flavie Luce Goutard2, Eve Miguel3

  • 1UEME, Institut Pasteur , Paris , France.

Insights

Experts believe direct and indirect contact with dromedary camels are the primary risks for Middle-East respiratory syndrome coronavirus (MERS-CoV) transmission to humans. Further research is needed to understand MERS-CoV transmission dynamics at the animal-human interface.

Area of Science:

  • Veterinary Medicine
  • Epidemiology
  • Zoonotic Diseases

Background:

  • Middle-East respiratory syndrome coronavirus (MERS-CoV) has caused over 1800 human cases since its emergence.
  • Understanding MERS-CoV ecology, epidemiology, and transmission risks, especially between dromedary camels and humans, remains limited.
  • Divergent sanitary situations and animal exposures present significant challenges in managing MERS-CoV globally.

Purpose of the Study:

  • To assess the relative importance of MERS-CoV risk factors.
  • To estimate transmission risks from various human-dromedary contact types.
  • To identify key knowledge gaps in MERS-CoV transmission at the animal-human interface.

Main Methods:

  • Expert-opinion elicitation using an online questionnaire.
  • Involved 14 experts with diverse experience in MERS-CoV relevant fields.
  • Examined transmission pathways including animal-animal, animal-human, role of other species, biological substances, and fomites.

Main Results:

  • Dromedary camels are considered the primary source of MERS-CoV transmission among themselves, influenced by seasons.
  • Infected dromedary camels and asymptomatic humans are the main sources of human MERS-CoV infection.
  • Direct (22%) and indirect (13%) contact with dromedary camels pose the highest MERS-CoV transmission risks compared to camel product consumption.

Conclusions:

  • Expert opinions align with limited existing data on MERS-CoV transmission pathways.
  • Direct and indirect contact with dromedary camels are significant risk factors for human MERS-CoV infection.
  • Focused research is crucial to better understand and mitigate MERS-CoV transmission between dromedaries and humans.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
94
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.6K
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
26.1K
Cross-reactivity00:42

Cross-reactivity

Overview
33.7K
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect01:26

Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect

The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
143
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.4K